The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 352:2268-2270 June 2, 2005 Number 22
NextNext

Type II Collagen and Avascular Necrosis of the Femoral Head
Darwin J. Prockop, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Liu, Y.-F.
-PubMed Citation
All of us carry millions of variations in the sequences of our genomes and thousands of mutations in genes, some of which alter the amino acid sequences of proteins. The majority of the variations in genomes and even many of the changes in the sequences of proteins have no apparent effect on the risk of death or on longevity. The challenge of current molecular genetics is to distinguish the neutral variations from mutations that alter the functions of proteins sufficiently to predispose us to disease.

In their study reported in this issue of the Journal, Liu et al. (pages 2294–2301) . . . [Full Text of this Article]


Source Information

Dr. Prockop is the director of the Center for Gene Therapy, Tulane University Health Sciences Center, New Orleans.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.